PEOPLE - Bristol-Myers Squibb (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Bristol-Myers Squibb (Princeton, New Jersey) has appointed three key senior directors for the department of corporate development. Jack Geltosky, who most recently served as president and CEO of Message Pharmaceuticals, has been appointed as vice-president of external science, technology and licensing. Graham Brazier, who most recently served as senior vice-president of corporate development at 3-Dimensional Pharmaceuticals, has been appointed as vice-president of business development. James Foley, who has been appointed as vice-president of business development in Japan and Asia, most recently served in the same capacity at GlaxoSmithKline.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.